Literature DB >> 8912295

Comparing three versions of the time tradeoff: time for a change?

J K Buckingham1, J Birdsall, J G Douglas.   

Abstract

This paper reports a comparative study of three formulations of the time-tradeoff (TTO) method of health valuation. One asks people to consider giving up time each day in exchange for better health. The second asks people to consider giving up time during a 12-month interval. The third is the more conventional TTO in which people are asked to contemplate a reduction in life expectancy. Questionnaires were sent to 4,087 adults selected at random from the population of Scotland. Each respondent provided a description of his or her health, and was asked to value an improvement in that health, using all three formulations of the TTO. The daily TTO appeared to be an improvement on the conventional formulation, correlating more strongly with health, eliciting responses that appeared to be more precise and obtaining information about the value of health from a far greater number of respondents. The performance of the annual TTO appeared to be only slightly inferior to that of the daily TTO.

Entities:  

Mesh:

Year:  1996        PMID: 8912295     DOI: 10.1177/0272989X9601600404

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  6 in total

Review 1.  Valuing health-related quality of life. A review of health state valuation techniques.

Authors:  C Green; J Brazier; M Deverill
Journal:  Pharmacoeconomics       Date:  2000-02       Impact factor: 4.981

2.  Glaucoma patients' assessment of their visual function and quality of life.

Authors:  H D Jampel
Journal:  Trans Am Ophthalmol Soc       Date:  2001

3.  Measuring preferences for schizophrenia outcomes with the time tradeoff method.

Authors:  Martha Shumway; Tandy L Chouljian; Cynthia L Battle
Journal:  J Behav Health Serv Res       Date:  2005 Jan-Mar       Impact factor: 1.505

Review 4.  Valuation of health states in the US study to establish disability weights: lessons from the literature.

Authors:  Jürgen Rehm; Ulrich Frick
Journal:  Int J Methods Psychiatr Res       Date:  2010-03       Impact factor: 4.035

5.  Recombinant erythropoietin for chemotherapy-related anaemia: economic value and health-related quality-of-life assessment using direct utility elicitation and discrete choice experiment methods.

Authors:  Diego F Ossa; Andrew Briggs; Emma McIntosh; Warren Cowell; Tim Littlewood; Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

6.  Valuation of symptomatic hepatitis a in adults: estimates based on time trade-off and willingness-to-pay measurement.

Authors:  R Jake Jacobs; Ronald J Moleski; Allen S Meyerhoff
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.